Gitanjali Srivastava

1.6k total citations · 1 hit paper
37 papers, 1.1k citations indexed

About

Gitanjali Srivastava is a scholar working on Pharmacology, Surgery and Physiology. According to data from OpenAlex, Gitanjali Srivastava has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 13 papers in Surgery and 13 papers in Physiology. Recurrent topics in Gitanjali Srivastava's work include Pharmacology and Obesity Treatment (18 papers), Bariatric Surgery and Outcomes (11 papers) and Diabetes Treatment and Management (11 papers). Gitanjali Srivastava is often cited by papers focused on Pharmacology and Obesity Treatment (18 papers), Bariatric Surgery and Outcomes (11 papers) and Diabetes Treatment and Management (11 papers). Gitanjali Srivastava collaborates with scholars based in United States, Germany and Brazil. Gitanjali Srivastava's co-authors include Caroline M. Apovian, Cynthia Buffington, Robert F. Kushner, Jiaxun Chen, Bruno Halpern, Shuyu Zhang, Sriram Machineni, Mathijs C. Bunck, Tammy Forrester and Nadia N. Ahmad and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and American Journal of Clinical Nutrition.

In The Last Decade

Gitanjali Srivastava

35 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial

2023 220 citations Thomas A. Wadden, Ariana M. Chao et al. Nature Medicine profile →

Peers

Gitanjali Srivastava

PHYSI

PHARM

EDM

SURGE

Cíntia Cercato Brazil

Barbara Troupin United States

Amélio F. Godoy‐Matos Brazil

Andrea Pucci United Kingdom

Garry D. Tan United Kingdom

Carol A. Maggio United States

Katrine Bagge Hansen Denmark

Maria Edna de Melo Brazil

Diane Smith United States

Amelia N. Pilichiewicz Australia

Cíntia Cercato Brazil

Gitanjali Srivastava

529 ×1.3

PHYSI

274 ×0.7

PHARM

362 ×1.0

EDM

226 ×1.0

SURGE

156 ×0.8

Citations per year, relative to Gitanjali Srivastava Gitanjali Srivastava (= 1×) peers Cíntia Cercato

Countries citing papers authored by Gitanjali Srivastava

Since Specialization

Citations

This map shows the geographic impact of Gitanjali Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gitanjali Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gitanjali Srivastava more than expected).

Fields of papers citing papers by Gitanjali Srivastava

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gitanjali Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gitanjali Srivastava. The network helps show where Gitanjali Srivastava may publish in the future.

Co-authorship network of co-authors of Gitanjali Srivastava

This figure shows the co-authorship network connecting the top 25 collaborators of Gitanjali Srivastava. A scholar is included among the top collaborators of Gitanjali Srivastava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gitanjali Srivastava. Gitanjali Srivastava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gourgari, Evgenia, Gitanjali Srivastava, Aaron S. Kelly, et al.. (2025). Early‐Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials. Obesity. 33(9). 1668–1679.

Samuels, Jason M., Fei Ye, Rebecca Irlmeier, et al.. (2025). Real‐world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic. Diabetes Obesity and Metabolism. 27(11). 6200–6209. 3 indexed citations

Srivastava, Gitanjali, Christine Hill, Takara L. Stanley, et al.. (2025). Novel strategies for medical management of obesity: mechanisms, clinical implications, and societal impacts—a report from the 25th Annual Harvard Nutrition Obesity Symposium. American Journal of Clinical Nutrition. 122(3). 866–885. 1 indexed citations

Nadler, Evan P., Marsha B. Novick, Melissa Santos, et al.. (2025). Clinical considerations in the management of obesity in children and adolescents. PubMed. 13. 100160–100160.

Wadden, Thomas A., Ariana M. Chao, Sriram Machineni, et al.. (2024). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3). Diabetologie und Stoffwechsel. 19(S 01). S83–S84. 1 indexed citations

Baker, Jennifer L., Carine de Beaufort, Ruth M. Belin, et al.. (2024). Considerations for the design and conduct of pediatric obesity pharmacotherapy clinical trials: Proceedings of expert roundtable meetings. Pediatric Obesity. 19(11). e13161–e13161. 2 indexed citations

Yan, Chao, Simon Vandekar, Danxia Yu, et al.. (2024). Association Between Patient Portal Engagement and Weight Loss Outcomes in Patients After Bariatric Surgery: Longitudinal Observational Study Using Electronic Health Records. Journal of Medical Internet Research. 26. e56573–e56573. 2 indexed citations

Srivastava, Gitanjali, et al.. (2024). The Latest Trends in the Management of Type 1 and Type 2 Diabetes Mellitus. SHILAP Revista de lepidopterología. 5(4). 566–584. 1 indexed citations

Srivastava, Gitanjali, et al.. (2023). Combined GLP-1 Receptor Agonist and Amylin Analogue Pharmacotherapy to Treat Obesity Comorbid With Type 1 Diabetes. JCEM Case Reports. 1(2). luad040–luad040. 7 indexed citations

10.

Wadden, Thomas A., Ariana M. Chao, Sriram Machineni, et al.. (2023). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nature Medicine. 29(11). 2909–2918. 220 indexed citations breakdown →

11.

Srivastava, Gitanjali, et al.. (2023). Obesity Management in Children and Adolescents. Gastroenterology Clinics of North America. 52(2). 443–455. 11 indexed citations

12.

Slaughter, James C., et al.. (2023). Prevalence of genetic causes of obesity in clinical practice. Obesity Science & Practice. 9(5). 508–515. 11 indexed citations

13.

Bajaj, Simar S., Bhav Jain, Theodore K. Kyle, et al.. (2022). Overcoming congressional inertia on obesity requires better literacy in obesity science. Obesity. 30(4). 799–801. 6 indexed citations

14.

Chaar, Maher El, Salvatore Docimo, Danbi Choi, et al.. (2022). Literature review on antiobesity medication use for metabolic and bariatric surgery patients from the American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. Surgery for Obesity and Related Diseases. 18(9). 1109–1119. 15 indexed citations

15.

Srivastava, Gitanjali, Claudia K. Fox, Aaron S. Kelly, et al.. (2019). Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity. Obesity. 27(2). 190–204. 102 indexed citations

16.

Srivastava, Gitanjali, et al.. (2018). Shape-Up and Eat Right Families Pilot Program: Feasibility of a Weight Management Shared Medical Appointment Model in African-Americans With Obesity at an Urban Academic Medical Center. Frontiers in Pediatrics. 6. 101–101. 9 indexed citations

17.

Srivastava, Gitanjali & Cynthia Buffington. (2018). Early weight loss outcomes from a newly established hospital-affiliated specialized obesity care delivery model in Central Florida. International Journal of Obesity. 43(1). 132–138. 7 indexed citations

18.

Srivastava, Gitanjali & Caroline M. Apovian. (2018). Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon. Current Obesity Reports. 7(2). 147–161. 160 indexed citations

19.

Srivastava, Gitanjali & Cynthia Buffington. (2018). A Specialized Medical Management Program to Address Post-operative Weight Regain in Bariatric Patients. Obesity Surgery. 28(8). 2241–2246. 33 indexed citations

20.

Srivastava, Gitanjali & Caroline M. Apovian. (2017). Current pharmacotherapy for obesity. Nature Reviews Endocrinology. 14(1). 12–24. 273 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact